Your browser doesn't support javascript.
loading
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.
Dimopoulos, Meletios A; San-Miguel, Jesus; Belch, Andrew; White, Darrell; Benboubker, Lotfi; Cook, Gordon; Leiba, Merav; Morton, James; Ho, P Joy; Kim, Kihyun; Takezako, Naoki; Moreau, Philippe; Kaufman, Jonathan L; Sutherland, Heather J; Lalancette, Marc; Magen, Hila; Iida, Shinsuke; Kim, Jin Seok; Prince, H Miles; Cochrane, Tara; Oriol, Albert; Bahlis, Nizar J; Chari, Ajai; O'Rourke, Lisa; Wu, Kaida; Schecter, Jordan M; Casneuf, Tineke; Chiu, Christopher; Soong, David; Sasser, A Kate; Khokhar, Nushmia Z; Avet-Loiseau, Hervé; Usmani, Saad Z.
Afiliação
  • Dimopoulos MA; The National and Kapodistrian University of Athens, Greece mdimop@med.uoa.gr.
  • San-Miguel J; Clínica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain.
  • Belch A; Department of Oncology, University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada.
  • White D; QEII Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Benboubker L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France.
  • Cook G; St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust and University of Leeds, UK.
  • Leiba M; Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Morton J; Icon Cancer Care, South Brisbane, QLD, Australia.
  • Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Takezako N; Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan.
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Sutherland HJ; Leukemia/Bone Marrow Transplant Program, University of British Columbia, Vancouver, Canada.
  • Lalancette M; CHU de Québec Research Center, Faculty of Medicine, Laval University, Canada.
  • Magen H; Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Kim JS; Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea.
  • Prince HM; Cabrini Hospital, Epworth HealthCare and Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia.
  • Cochrane T; Gold Coast University Hospital, Southport, QLD, Australia.
  • Oriol A; Institut Català d'Oncologia i Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain.
  • Bahlis NJ; University of Calgary, Arnie Charbonneau Cancer Institute, Alberta, Canada.
  • Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • O'Rourke L; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Wu K; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Schecter JM; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Casneuf T; Janssen Research & Development, Beerse, Belgium.
  • Chiu C; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Soong D; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Sasser AK; Genmab US, Inc, Princeton, NJ, USA.
  • Khokhar NZ; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Avet-Loiseau H; Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France.
  • Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
Haematologica ; 103(12): 2088-2096, 2018 12.
Article em En | MEDLINE | ID: mdl-30237262
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Avaliação de Resultados em Cuidados de Saúde / Neoplasia Residual / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Avaliação de Resultados em Cuidados de Saúde / Neoplasia Residual / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article